IUPAC Name |
(1s,2s)-1-[(2s)-2-[(3s,6s)-6-(2-amino-2-oxo-ethyl)-5,8-dioxo-12-oxa-4,7-diazabicyclo[11.2.2]heptadeca-1(16),13(17),14-trien-3-yl]-2-hydroxy-ethyl]-n-[(1s,2s)-1-[[(1s)-1-carbamoyl-2-methyl-propyl]carbamoyl]-2-methyl-butyl]pyrrolidine-2-carboxamide |
Synonyms
|
- (2s)-1-[(2s)-2-[(3s,6s)-6-(2-amino-2-keto-ethyl)-5,8-diketo-12-oxa-4,7-diazabicyclo[11.2.2]heptadeca-1(16),13(17),14-trien-3-yl]-2-hydroxy-ethyl]-n-[(1s,2s)-1-[[(1s)-1-carbamoyl-2-methyl-propyl]carbamoyl]-2-methyl-butyl]pyrrolidine-2-carboxamide
- (2s)-1-[(2s)-2-[(3s,6s)-6-(2-amino-2-oxo-ethyl)-5,8-dioxo-12-oxa-4,7-diazabicyclo[11.2.2]heptadeca-1(16),13(17),14-trien-3-yl]-2-hydroxy-ethyl]-n-[(1s,2s)-1-[[(1s)-1-carbamoyl-2-methyl-propyl]carbamoyl]-2-methyl-butyl]pyrrolidine-2-carboxamide
- (2s)-1-[(2s)-2-[(3s,6s)-6-(2-amino-2-oxoethyl)-5,8-dioxo-12-oxa-4,7-diazabicyclo[11.2.2]heptadeca-1(16),13(17),14-trien-3-yl]-2-hydroxyethyl]-n-[(1s,2s)-1-[[[(1s)-1-carbamoyl-2-methylpropyl]amino]-oxomethyl]-2-methylbutyl]-2-pyrrolidinecarboxamide
- (2s)-n-[(2s,3s)-1-[[(2s)-1-amino-3-methyl-1-oxo-butan-2-yl]amino]-3-methyl-1-oxo-pentan-2-yl]-1-[(2s)-2-[(3s,6s)-6-(2-amino-2-oxo-ethyl)-5,8-dioxo-12-oxa-4,7-diazabicyclo[11.2.2]heptadeca-1(16),13(17),14-trien-3-yl]-2-hydroxy-ethyl]pyrrolidine-2-carboxamide
- (2s)-n-[(2s,3s)-1-[[(2s)-1-amino-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-1-[(2s)-2-[(3s,6s)-6-(2-amino-2-oxoethyl)-5,8-dioxo-12-oxa-4,7-diazabicyclo[11.2.2]heptadeca-1(16),13(17),14-trien-3-yl]-2-hydroxyethyl]pyrrolidine-2-carboxamide
- 1-[2-(8-carbamoylmethyl-6,9-dioxo-2-oxa-7,10-diaza-bicyclo[11.2.2] heptadeca-1(16),13(17),14-trien-11-yl)-2-hydroxy-ethyl] -pyrrolidine-2-carboxylic acid [1-(1-carbamoyl-2-methyl-propylcarbamoyl) -2-methyl-butyl]-amide
- 2-[((2s)-1-{(2s)-2-[(3s,6s)-4,7-diaza-6-(carbamoylmethyl)-12-oxa-5,8-dioxobicyclo[11.2.2]heptadeca-1(15),13,16-trien-3-yl]-2-hydroxyethyl}pyrrolidin-2-yl)carbonylamino]-n-((1s)-1-carbamoyl-2-methylpropyl)(2s,3s)-3-methylpentanamide
- macrocyclic peptidomimetic inhibitor 1
- pi1
|